• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

21种透明质酸填充剂对重组人透明质酸酶的反应

Response of 21 Hyaluronic Acid Fillers to Recombinant Human Hyaluronidase.

作者信息

Park Kristen E, Mehta Preeya, Kherani Femida, Lee Wendy W, Woodward Julie A, Foster Jill A, Zhang-Nunes Sandy

机构信息

Department of Ophthalmology, Ohio State University, Columbus, Ohio.

Department of Ophthalmology, New York University, New York City, N.Y.

出版信息

Plast Reconstr Surg Glob Open. 2023 Dec 22;11(12):e5457. doi: 10.1097/GOX.0000000000005457. eCollection 2023 Dec.

DOI:10.1097/GOX.0000000000005457
PMID:38145149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10745246/
Abstract

BACKGROUND

One benefit of hyaluronic acid fillers is the ability to dissolve them using hyaluronidase. With the increasing number of fillers entering the market, it is crucial to understand each of these fillers' responsiveness to hyaluronidase.

METHODS

Twenty-one hyaluronic acid fillers of 0.2 mL aliquots each were placed on slides. Twenty units of recombinant human hyaluronidase were injected into the aliquots every 30 minutes for a total of 120 units recombinant human hyaluronidase injected over 3 hours. With each injection, videos and photographs were taken from bird's eye and lateral views to measure aliquot height. Stirring videos were graded by three oculoplastic surgeons, and these grades were used to categorize each filler's responsiveness.

RESULTS

Restylane Lyft, Restylane-L/Eyelight, and Resilient Hyaluronic Acid (RHA) 1/Redensity were the least resistant. The moderately resistant group comprised of Restylane Silk, Juvéderm Volbella, Revanesse Versa/Lips, and Belotero Balance on the less resistant side to Juvéderm Vollure, RHA 2, Restylane Contour, Juvéderm Ultra, Restylane Refyne, Belotero Intense, Restylane Kysse, RHA 3, Juvéderm Ultra Plus, and Restylane Defyne on the more resistant side. The most resistant were RHA 4, Juvéderm Voluma, Belotero Volume, and Juvéderm Volux. The most resistant fillers required 120 units of hyaluronidase per 0.2 mL filler to dissolve.

CONCLUSIONS

With the increasing popularity of fillers comes the increasing need to dissolve them for both ischemic and nonischemic complications. The majority of hyaluronic acid fillers available on the market are very resistant to hyaluronidase, which must be considered when determining the amount of hyaluronidase to dissolve a particular filler.

摘要

背景

透明质酸填充剂的一个优点是能够使用透明质酸酶将其溶解。随着越来越多的填充剂进入市场,了解每种填充剂对透明质酸酶的反应至关重要。

方法

将21份每份0.2 mL的透明质酸填充剂置于载玻片上。每30分钟向每份填充剂中注射20单位重组人透明质酸酶,3小时内共注射120单位重组人透明质酸酶。每次注射时,从鸟瞰和侧视图拍摄视频和照片,以测量每份填充剂的高度。由三位眼整形医生对搅拌视频进行评分,这些评分用于对每种填充剂的反应性进行分类。

结果

瑞蓝丽芙、瑞蓝-L/明眸、弹性透明质酸(RHA)1/瑞得喜是最不耐受的。中等耐受组包括瑞蓝丝柔、乔雅登雅致、瑞婉致/唇部、贝洛特罗平衡,它们对透明质酸酶的耐受性稍低,而乔雅登极致、RHA 2、瑞蓝塑形、乔雅登经典版、瑞蓝柔致、贝洛特罗深层、瑞蓝吻痕、RHA 3、乔雅登极致加强版和瑞蓝定致对透明质酸酶的耐受性稍高则在更耐受的一侧。最耐受的是RHA 4、乔雅登丰颜、贝洛特罗大容量和乔雅登极塑。最耐受的填充剂每0.2 mL填充剂需要120单位透明质酸酶才能溶解。

结论

随着填充剂越来越受欢迎,如果出现缺血性和非缺血性并发症时溶解填充剂的需求也日益增加。市场上大多数可用的透明质酸填充剂对透明质酸酶具有很强抗性,在确定溶解特定填充剂所需透明质酸酶量时必须考虑这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f075/10745246/bb6cddb330e1/gox-11-e5457-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f075/10745246/5c09442149e3/gox-11-e5457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f075/10745246/a4aaedd4e5cd/gox-11-e5457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f075/10745246/bb6cddb330e1/gox-11-e5457-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f075/10745246/5c09442149e3/gox-11-e5457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f075/10745246/a4aaedd4e5cd/gox-11-e5457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f075/10745246/bb6cddb330e1/gox-11-e5457-g003.jpg

相似文献

1
Response of 21 Hyaluronic Acid Fillers to Recombinant Human Hyaluronidase.21种透明质酸填充剂对重组人透明质酸酶的反应
Plast Reconstr Surg Glob Open. 2023 Dec 22;11(12):e5457. doi: 10.1097/GOX.0000000000005457. eCollection 2023 Dec.
2
Response of twelve different hyaluronic acid gels to varying doses of recombinant human hyaluronidase.十二种不同透明质酸凝胶对不同剂量重组人透明质酸酶的反应。
J Plast Reconstr Aesthet Surg. 2021 Apr;74(4):881-889. doi: 10.1016/j.bjps.2020.10.051. Epub 2020 Nov 6.
3
Prospective in vivo evaluation of three different hyaluronic acid gels to varying doses of hyaluronidase with long-term follow-up.前瞻性体内评估三种不同透明质酸凝胶与不同剂量透明质酸酶的长期随访。
J Plast Reconstr Aesthet Surg. 2021 Apr;74(4):874-880. doi: 10.1016/j.bjps.2020.10.052. Epub 2020 Nov 6.
4
The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.用透明质酸酶治疗的可逆性透明质酸填充剂注射的动力学
Dermatol Surg. 2017 Jun;43(6):841-847. doi: 10.1097/DSS.0000000000001084.
5
Molecular weight analyses and enzymatic degradation profiles of the soft-tissue fillers Belotero Balance, Restylane, and Juvéderm Ultra.软组织填充剂 Belotero Balance、Restylane 和 Juvéderm Ultra 的分子量分析和酶降解谱。
Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):22S-32S. doi: 10.1097/PRS.0b013e31829e88a3.
6
Reversing facial fillers: interactions between hyaluronidase and commercially available hyaluronic-acid based fillers.面部填充剂的逆转:透明质酸酶与市售透明质酸基填充剂之间的相互作用
J Drugs Dermatol. 2014 Sep;13(9):1053-6.
7
Hyaluronic Acid Fillers: Science and Clinical Uses.透明质酸填充剂:科学与临床应用。
Clin Plast Surg. 2016 Jul;43(3):489-96. doi: 10.1016/j.cps.2016.03.016. Epub 2016 May 5.
8
Quantifying the Digestion of Cross-Linked Hyaluronic Acid Fillers With Hyaluronidase.定量分析透明质酸酶对交联透明质酸填充物的消化作用。
Dermatol Surg. 2021 Sep 1;47(9):1233-1236. doi: 10.1097/DSS.0000000000003090.
9
Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications.透明质酸软组织填充剂的生物物理特性及其与美容应用的相关性。
Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):5S-21S. doi: 10.1097/PRS.0b013e31829d1d40.
10
Filler frontier: what's new and heading West to the US market.填充前沿:美国市场有哪些新动向以及西进趋势。
Semin Cutan Med Surg. 2014 Dec;33(4):157-63. doi: 10.12788/j.sder.0116.